Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Burns

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Internet Research|February 9, 2023
Parent-Reported Use of Pediatric Primary Care Telemedicine: Survey StudyKristin N Ray, Samuel R Wittman, Sarah Burns, et al.
Stem Cell Reviews and Reports|November 4, 2020
Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?Hal E Broxmeyer, Yan Liu, Reuben Kapur, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2026
Cytoplasmic region of beta-dystroglycan is essential for postsynaptic maturation and neuromuscular function in miceJeffrey M Hord, Rolf Turk, Hajime Kusano, et al.
The Journal of Infection|June 19, 2021
Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unitRossella Baldan, Penelope R Cliff, Sarah Burns, et al.
Blood|June 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 TrialSteven Knapper, Abin Thomas, Robert K Hills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 TrialNigel H Russell, Abin Thomas, Robert K Hills, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Leukemia|February 13, 2021
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasmRichard A Salisbury, Natalia Curto-Garcia, Jennifer O'Sullivan, et al.
BMJ (Clinical Research Ed.)|September 16, 2020
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19Nisreen A Alwan, Emily Attree, Jennifer Mary Blair, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Internet Research|February 9, 2023
Parent-Reported Use of Pediatric Primary Care Telemedicine: Survey StudyKristin N Ray, Samuel R Wittman, Sarah Burns, et al.
Stem Cell Reviews and Reports|November 4, 2020
Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?Hal E Broxmeyer, Yan Liu, Reuben Kapur, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2026
Cytoplasmic region of beta-dystroglycan is essential for postsynaptic maturation and neuromuscular function in miceJeffrey M Hord, Rolf Turk, Hajime Kusano, et al.
The Journal of Infection|June 19, 2021
Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unitRossella Baldan, Penelope R Cliff, Sarah Burns, et al.
Blood|June 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 TrialSteven Knapper, Abin Thomas, Robert K Hills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 TrialNigel H Russell, Abin Thomas, Robert K Hills, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Leukemia|February 13, 2021
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasmRichard A Salisbury, Natalia Curto-Garcia, Jennifer O'Sullivan, et al.
BMJ (Clinical Research Ed.)|September 16, 2020
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19Nisreen A Alwan, Emily Attree, Jennifer Mary Blair, et al.
Pageof 2